FDA Inspection 1294814 — Corden Pharma Colorado, Inc.
The FDA completed an inspection of Corden Pharma Colorado, Inc. on Nov 14, 2025 in Boulder, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 14, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Boulder, CO (United States)